REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Globion India Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Globion India Private Limited Profile Updated: November 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

The company develops and provides biotech solutions and nutritional products, including the GlobiVac ND Chick vaccine. The company operates in the biotech industry.

Legal Address
2/211-B, Viswanathapuram, Thudiyalur Post,M T P Road, Coimbatore
Coimbatore; Tamil Nadu; Postal Code: 641034

Contact Details: Purchase the Globion India Private Limited report to view the information.

Website: http://www.globionindia.com

Basic Information
Total Employees:
Purchase the Globion India Private Limited report to view the information.
Outstanding Shares:
Purchase the Globion India Private Limited report to view the information.
Registered Capital:
Purchase the Globion India Private Limited report to view the information.
Financial Auditors:
Purchase the Globion India Private Limited report to view the information.
Incorporation Date:
October 18, 2006
Key Executives
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
CFO
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
74%
Company Performance
Financial values in the chart are available after Globion India Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
2.88%▲
Total operating revenue
2.8%▲
Operating profit (EBIT)
-37.18%▼
EBITDA
-28.15%▼
Net Profit (Loss) for the Period
-45.39%▼
Total assets
-12.04%▼
Total equity
39.98%▲
Operating Profit Margin (ROS)
-12.14%▼
Net Profit Margin
-10.89%▼
Return on Equity (ROE)
-17.77%▼
Quick Ratio
3.1%▲
Cash Ratio
-0.16%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo